ATI RN
ATI Pharmacology NRSG 106 Fletcher Exam Questions
Extract:
Question 1 of 5
A nurse is providing teaching for a client who has diabetes and a new prescription for insulin glargine. Which of the following instructions should the nurse provide regarding this type of insulin?
Correct Answer: D
Rationale: Insulin glargine is a long-acting insulin that provides a steady, continuous level of insulin for up to 24 hours, typically administered once daily. The correct duration is 18 to 24 hours, making option D accurate.
Question 2 of 5
A nurse is teaching a client who has asthma about how to use an albuterol inhaler. Which of the following actions by the client indicates an understanding of the teaching?
Correct Answer: D
Rationale: Holding the breath for 10 seconds after inhaling albuterol allows the medication to settle in the lungs, enhancing efficacy, indicating understanding, making option D correct.
Question 3 of 5
A nurse is teaching a client who has a new prescription for prednisone to treat rheumatoid arthritis. The nurse should inform the client that which of the following is a therapeutic effect of this medication?
Correct Answer: A
Rationale: Prednisone reduces inflammation by suppressing immune responses, relieving rheumatoid arthritis symptoms, making option A the therapeutic effect.
Question 4 of 5
A nurse is reviewing discharge instructions with a client who has rheumatoid arthritis and a new prescription for prednisone. Which of the following statements by the client indicates an understanding of the teaching?
Correct Answer: B
Rationale: Prednisone can cause hypokalemia, and bananas are a potassium-rich food, helping to maintain electrolyte balance, indicating the client understands the dietary needs associated with this medication.
Question 5 of 5
A nurse is teaching a client who is to begin taking tamoxifen to treat breast cancer. The nurse should instruct the client to expect which of the following findings as an adverse effect of the medication?
Correct Answer: B
Rationale: Tamoxifen increases the risk of thromboembolic events, such as clots, a serious adverse effect to monitor, making option B the expected finding.